District Court for the Northern District of Illinois delivered a unanimous defense verdict on August 31, 2026, in favor of Mead Johnson in the Inman case, according to official company statements. The decision marks the first bellwether trial against the manufacturer within the federal Multi-District Litigation involving allegations that specialized preterm hospital nutrition products cause necrotizing enterocolitis, a severe gastrointestinal condition primarily impacting premature infants.
Court Rulings and Current Litigation Status
According to Mead Johnson, the Inman verdict leaves the company with no outstanding jury verdicts against it in the broader necrotizing enterocolitis litigation. Prior state-level trials, including the Collins and Whitfield cases, also resulted in defense verdicts for the manufacturer. Additionally, the Illinois Appellate Court previously reversed the Watson decision, according to company records.
The proceedings highlighted the clinical role that specialized hospital nutrition products play in supporting vulnerable infants in neonatal intensive care units when maternal or donor milk is unavailable or insufficient.
Scientific Consensus and Product Safety
Mead Johnson stated that the trial outcome affirms its position that available science does not support claims that its specialized nutrition products cause necrotizing enterocolitis. The company rejected assertions linking its formulas to the condition and stated its intention to defend against remaining claims.
According to the company, neonatologists recommend specialized preterm hospital nutrition products as part of standard neonatal intensive care unit care when clinically appropriate to address complex dietary needs. Mead Johnson maintains that these products provide essential nutrition for vulnerable newborns.
Frequently Asked Questions
What was the outcome of the Inman trial?
District Court for the Northern District of Illinois returned a unanimous verdict in favor of the company on August 31, 2026.
What is necrotizing enterocolitis?
Necrotizing enterocolitis is a serious gastrointestinal condition that primarily affects premature infants in neonatal intensive care settings.
Are there other pending jury verdicts against Mead Johnson regarding these claims?
According to company disclosures, there are currently no outstanding adverse jury verdicts against Mead Johnson in the overall litigation, following favorable rulings in the Collins and Whitfield state cases and the reversal of the Watson decision.
Related reading